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Abstract
In recent years, countries around the world have revised their blood donation policies regarding gay and bisexual
men, and other men who have sex with men (MSM). The United States lifted the lifetime ban on MSM from
donating blood in 2015, replacing it with a 1 year deferral policy allowing MSM to donate if they abstain from sex
for 12 months. Other countries followed suit, while Italy and Spain have implemented deferral policies based on
individual risk assessments regardless of sexual orientation. If Israel were to adopt a one year deferral policy for
MSM, as recommended by Drs. Ginsberg et al. in this issue, the increase in risk to the blood supply would be
minimal. Moving to a 1 year deferral policy would be an important step forward, but it could still be seen as
stigmatizing to gay and bisexual men. We recommend that Israel consider a deferral policy based on individual risk
assessment rather than a blanket deferral for all MSM. MSM can engage in low- and high-risk sexual behaviors.
Those who consistently engage in low-risk behaviors, such as using condoms and pre-exposure prophylaxis
consistently, pose little risk to the blood supply. An individual risk assessment policy would screen potential donors
of all sexual orientations for low-, medium-, and high-risk behaviors. Potential donors identified as high-risk, such as
injection drug users, would justifiably be subject to lengthy or permanent bans. MSM who engage in low-risk
sexual behaviors would be allowed to donate without deferral. Medium-risk donors, such as men who have
recently had unprotected anal sex with another man, would be subject to a deferral period of 1 month, which is in
line with the window period of current HIV screening technology. Most fourth generation HIV tests can detect HIV
within a month, and the nucleic acid test used to screen blood can detect HIV in just 9–11 days. Various studies
have developed questions for ascertaining HIV risk among MSM which could be used in blood donor
questionnaires. Using tablets or other technology that enhances privacy to conduct the blood donor questionnaire
could improve collection of this sensitive information.
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Background
In recent years several countries have revised their pol-
icies regarding blood donation by men who have sex
with men (MSM). These changes have occurred due to
advances in blood screening technology, and due to an
acknowledgement of the stigmatizing nature of the
lifetime MSM blood donation, and the desire of many
low-risk MSM to contribute to disaster preparedness
and a strengthening of the blood supply.
The United States ended its lifetime ban on MSM
blood donations and adopted a 1-year deferral policy in
2015, meaning that MSM must abstain from sex for
1 year to be eligible to donate blood [1]. Canada reduced
its lifetime deferral for MSM to 5 years in 2013 and to
1 year in 2016 [2]. South Africa, had a 6-months deferral
policy for MSM until 2014. Now people are deferred if
they have a new sexual partner in the past 6 months [3]
or report multiple partners in the past 6 months [4],
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regardless of the sex of those partners. Russia lifted a
ban on MSM donating blood in 2008, but government
officials were considering reinstating the ban after pass-
ing anti-gay laws in 2013 [5]. France ended its lifetime
ban on MSM blood donations in 2016. MSM who have
not been sexually active with other men in the past year
are now eligible to donate blood in France. Gay men
who have only had one partner in the preceding
4 months, or who have not been sexually active, can do-
nate blood plasma. The French Health Ministry will con-
tinue to conduct studies, and the deferral period for gay
men will gradually be reduced if there are no increases
in health risks [6].
As of 2015, Austria, Germany and Belgium still had
lifetime bans for MSM who wish to donate blood [6].
The lifetime ban on MSM donating blood was lifted in
2011 in England, Scotland, and Wales, and in 2016 in
Northern Ireland. It was replaced with a 1-year deferral
period for sexually active MSM. The British government
is now conducting a review to see if the deferral policy
should be shortened [7]. Japan, the Netherlands,
Australia and New Zealand all have 1-year deferrals for
MSM blood donation [6]. In Italy and Spain, donors are
screened for high-risk sexual behavior regardless of the
sex of their partners or their sexual orientation. Deferrals
are made based on individual risk [6].
Commentary
In their paper in the current issue of the Israel Journal
of Health Policy Research [8], Drs. Ginsberg, Shinar,
Kopel and Chemtob analyze this important public health
policy, which currently bans Israeli men from donating
if they have had sex with another man since 1977, and
recommend a shift to a 1-year deferral. In other words,
an MSM who seeks to donate would have to abstain
from sexual activity for 1 full year before donating. Such
a change in policy would result in a minimal increase in
risk in Israel—1 transfusion transmission incident, or
TTI, per century. The increased risk estimate from mov-
ing from a lifetime MSM ban to a 5-years deferral policy
in Israel would be 1 TTI over 2 centuries. However,
Ginsberg et al. estimate that a complete end to the
MSM blood donation ban with no deferral period during
which an MSM donor had to abstain from sex would
lead to a six-fold increase of risk of a TTI: 4.99 TTIs
over the next decade.
Were the Israeli government to implement the
Ginsberg et al.’s recommendation, this would represent
an important incremental step towards a science-based
policy which maintains the safety of the blood supply
without stigmatizing gay and bisexual men. While no
one has a right to donate blood, and therefore the
current policy is not discriminatory in the way anti-gay
discrimination in employment or housing is, a change in
policy to allow some low-risk MSM to donate blood
would reduce stigma against MSM, and be in line with
Israel’s relatively enlightened treatment of sexual minor-
ities under public policy, especially in contrast how gay,
lesbian and bisexual people fare in other countries in the
Middle East [9].
The nucleic acid test (NAT) used to screen blood can
detect HIV in just 9–11 days after infection [10]. New
technological advances greatly decrease the risk of HIV-
infected blood escaping detection; however, they cannot
completely eliminate the risk of HIV in the blood supply.
Therefore, NAT technology should be used in conjunc-
tion with comprehensive individual risk assessments that
can adequately screen potential donors for low- and
high-risk sexual behaviors.
A lifetime ban on blood donations by MSM, which is
Israel’s current policy and which was the policy of the
United States until late 2015, is based on a flawed under-
standing of male same-sex behavior. Sexually active gay
and bisexual men who are at low risk (i.e. who are mon-
ogamous with an HIV-negative partner, who use con-
doms and lubricant, or who don’t have receptive anal
intercourse without a condom) are not allowed to do-
nate. Many gay men have sex but don’t have condomless
anal sex. Most gay and bisexual men are HIV-negative
[11], and most are not at high risk of HIV infection, yet
they are denied the ability to donate blood under the
current lifetime ban. A meta-analysis by Beyrer, Baral,
van Griensven et al. found that HIV prevalence among
MSM ranges from a low of 3.0% in the Middle East and
North Africa region to 25.4% in the Caribbean. Preva-
lence among MSM in Western Europe is 6.1%, in
Eastern Europe and Central Asia 6.6%, and in North
America 15.4% [11].
Israel should consider going beyond the recommenda-
tions of Ginsberg et al., and consider a deferral policy
based on individual risk assessment rather than a blan-
ket deferral for all sexually active MSM. A more rational
policy based on individual risk assessment would identify
low-, medium-, and high-risk potential donors. Low-risk
MSM, such as those who have not had any anal sex re-
cently or those who exclusively used condoms during
sex, would be allowed to donate without deferral. High-
risk potential donors of any sexual orientation, such as
those who ever injected drugs or performed commercial
sex work, would continue to be subject to the lifetime
ban on donating blood as indicated by the current
United States protocol [1]. Potential MSM donors who
are identified as medium-risk, including those who have
engaged in higher risk sexual behaviors such as recent
unprotected anal sex, would be subject to a 30-days tem-
porary deferral before being allowed to donate.
Often donor history questionnaires do not adequately
distinguish between lower and higher risk sexual
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behaviors by MSM donors or others. Both MSM and
non-MSM donors can engage in low-risk sexual behav-
iors, or high-risk sexual behaviors. In addition, certain
sexual acts are more high-risk for acquiring HIV than
others (see Additional file 1: Table S1) [12]. For example,
receptive anal intercourse without protection from con-
doms and lubricant and/or pre-exposure prophylaxis
(PrEP) is much higher risk than oral intercourse.
The most effective questions for identifying individuals
at risk of transmitting HIV through blood donation
would screen out potential donors who engage in high-
risk sexual behaviors. Questions to identify the risk of
potential donors already exist in the U.S. donor history
questionnaire. To differentiate between low- and
medium-risk MSM donors, the individual risk assess-
ment questions should focus on recent (within 2–4
weeks) sexual history. Low risk donors would include,
for example, those who have not had any recent anal sex
and those who consistently use condoms and/or PrEP
[13]. Low risk MSM should be allowed to donate with-
out a temporary deferral. MSM donors that are deter-
mined to be medium risk should be subject to a short
deferral period. Based on epidemiological research and
U.S. Centers for Disease Control and Prevention (CDC)
recommendations, criteria for being classified as medium
risk can include:
 having multiple, casual male partners in the last
2–4 weeks
 having any unprotected anal sex with a man in the
last 2–4 weeks
 having 1 or more HIV-positive partners in the last
2–4 weeks
 having a recent diagnosis or history of gonorrhea,
chlamydia, and/or syphilis
MSM donors determined to be medium risk could be
subject to a temporary deferral period of 30 days. Defer-
ral periods that are substantially in excess of known win-
dow periods provide little additional value to ensuring
disease detection [14]. Different studies have estimated
the window period for various fourth-generation HIV
tests to be approximately 2 weeks to 1 month in length
[15]. Therefore, after a deferral period of 30 days, poten-
tial donors who are HIV-positive should be detected by
current HIV testing technology.
The U.S. CDC and the U.S. Public Health Service
released PrEP guidance in 2014 [16]. In a supple-
ment for providers, a risk index tool is provided “to
quickly and systematically determine which MSM
are at especially high risk of acquiring HIV
infection” [16]. This risk index contains several
questions for determining high-risk of acquiring
HIV (see Additional file 1: Table S2) [16].
The MSM Risk Index was based on several epidemio-
logical studies. One study developed and validated a pre-
diction model for HIV acquisition among MSM based
on medical records data from a United States sexually
transmitted diseases (STD) clinic from 2001 to 2008.
The predictive model generates a risk score based on
previous history of STDs, drug use, sex with HIV-
positive partners, and number of sexual partners. The
study provided a simplified risk score estimation tool
that includes specific questions for ascertaining high
HIV risk (see Additional file 1: Table S3) [17].
The questions that are recommended by the CDC and
the U.S. Public Health Service in their PrEP guidelines
ask about specific high-risk sexual practices. These ques-
tions were designed specifically for MSM, so they should
be understandable and acceptable to potential MSM do-
nors. Blood donation centers should ask all potential do-
nors about high-risk behaviors, but they could also
structure their questionnaire such that men who indicate
that they have sex with other men are asked a particular
set of questions such as those described above.
The blood bank industry should consider administer-
ing donor risk questionnaires using tablets, such as
iPads, which convey a greater sense of confidentiality
and could lead to more accurate reporting of risk data
and a greater ability to screen out high-risk would-be
donors [18]. Reassuring all donors that any information
provided on the donor history questionnaire will be kept
confidential, and using technologies that enhance a
sense of privacy, can facilitate the collection of sensitive
data. Research has shown that use of technologies that
minimize responding directly to a questioner has been
shown to facilitate the collection of sensitive data, includ-
ing sexual orientation, substance use, and mental health
data. Respondents to a sexual health survey who used
telephone audio computer-assisted self-interviewing (T-
ACASI) instead of human interviewers were 1.5–1.6 times
more likely to report same-gender sexual attraction, ex-
perience, and genital contact. The impact of T-ACASI was
more pronounced (odds ratio = 2.5) for residents of com-
munities that were less accepting of homosexuality and
for respondents who were parents raising children (odds
ratio = 3.0) [19]. A related technology is the use of elec-
tronic patient-reported outcomes (ePRO) tablets in clin-
ical settings. ePRO tablets have been shown effective in
collecting sensitive information from HIV patients, in-
cluding injection drug use, depression, and treatment ad-
herence data [18]. Given the experience with T-ACASI
and ePRO, it is likely that the use of tablet technology to
administer the donor history questionnaire would lead to
more accurate responses to individual risk assessments,
thereby increasing the ability of blood banks and other
blood donation centers to screen out potential high-risk
blood donors.
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Because these individual risk assessment questions are
sensitive in nature, it will be necessary to train staff who
will be working with potential donors in cultural compe-
tency to do a sexual history with a gay or bisexual man.
The Fenway Institute at Fenway Health in Boston, U.S.
[20], and the (U.S.) National LGBT Health Education
Center offer resources and training on LGBT cultural
competency [21].
Conclusions
An end to Israel’s lifetime blood donation ban for MSM
would be a major step toward a science-based policy
that reduces stigma for gay and bisexual men. Effective
risk behavior questions exist that could allow for an in-
dividual risk assessment to allow low-risk MSM to do-
nate with no deferral.
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